Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), with a substantial market capitalization of $110.13 billion, continues to ...

However, healthcare is a necessity. And the healthcare sector is poised to grow over the next decade and beyond with aging populations around the world. These factors make healthcare stocks a great ...

The commitment of organizations like the Cystic Fibrosis Foundation to global research funding and access initiatives has further propelled market growth. Additionally, major pharmaceutical companies, ...

Four of the top 10 drugs by prescription sales in 2025 will be from the new incretin class, according to the latest analysis by Evaluate. Consensus forecasts for Ozempic, Wegovy, Mounjaro and Zepbound ...

This was the stock's second consecutive day of gains.

For the week ended Jan. 17, 29 stocks saw their Morningstar Ratings change to 2 stars, while three climbed into 1-star ...

Workiva benefits from a growing Total Addressable Market driven by ESG adoption. Read more to see why I recommend a Buy ...

Forecasts for weak iPhone sales and a weaker update of new artificial intelligence features prompted strategists led by Edison Lee to lower the rate to Underperform from Hold.

Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the company has ...

Mankind Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Royalty Income for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the company has ...